1-5 of 5
Paul J. Hengeveld
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genetic drivers in the natural history of chronic lymphocytic leukemia development as early as 16 years before diagnosis

P. Martijn Kolijn, Florentin Späth, Mouhamad Khouja, Paul J. Hengeveld, Lina van der Straten, Nikos Darzentas, Magnus Hultdin, James D. McKay, Christiane Pott, Roel C. H. Vermeulen, Anton W. Langerak
Journal: Blood
Blood (2023) 142 (16): 1399–1403.
https://doi.org/10.1182/blood.2023019609
Published: 2023
Includes: Supplemental data
Journal Articles

Detecting measurable residual disease beyond 10 −4 by an IGHV leader-based NGS approach improves prognostic stratification in CLL

Paul J. Hengeveld, Michèle Y. van der Klift, P. Martijn Kolijn, Frédéric Davi, François G. Kavelaars, Evert de Jonge, Sandra Robrecht, Jorn L. J. C. Assmann, Lina van der Straten, Matthias Ritgen, Peter E. Westerweel, Kirsten Fischer, Valentin Goede, Michael Hallek, Mark-David Levin, Anton W. Langerak
Journal: Blood
Blood (2023) 141 (5): 519–528.
https://doi.org/10.1182/blood.2022017411
Published: 2023
Includes: Supplemental data
Journal Articles

High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis

Brief Report
P. Martijn Kolijn, Fatemeh Saberi Hosnijeh, Florentin Späth, Paul J. Hengeveld, Andreas Agathangelidis, Manal Saleh, Delphine Casabonne, Yolanda Benavente, Mats Jerkeman, Antonio Agudo, Aurelio Barricarte, Caroline Besson, Maria-Jose Sánchez, María-Dolores Chirlaque, Giovanna Masala, Carlotta Sacerdote, Sara Grioni, Matthias B. Schulze, Alexandra Nieters, Peter Engelfriet, Magnus Hultdin, James D. McKay, Roel C.H. Vermeulen, Anton W. Langerak
Journal: Blood
Blood (2022) 139 (10): 1557–1563.
https://doi.org/10.1182/blood.2021012890
Published: 2022
Includes: Supplemental data
Journal Articles

Characterization of Lineage Vs. Context-Dependent Essential Genes in Multiple Myeloma Using Crispr/Cas9 Genome Editing

Geoffrey M. Matthews, PhD, Ricardo De Matos Simoes, PhD, Yiguo Hu, MD PhD, Michal Sheffer, PhD, Eugen Dhimolea, PhD, Paul J. Hengeveld, B.Sc., Megan A. Bariteau, BSc, Brian Glassner, PhD, Quinlan Sievers, BA, Benjamin L. Ebert, MD PhD, Sara Gandolfi, MD, Pallavi Awate, MSc, Huihui Tang, PhD, Franciska Vazquez, PhD, Aedin Culhane, PhD, Constantine S Mitsiades, MD PhD
Journal: Blood
Blood (2016) 128 (22): 119.
https://doi.org/10.1182/blood.V128.22.119.119
Published: 2016
Journal Articles

Systematic Evaluation of Preclinical Genetically Determined Vs. "Stochastic"/Transient Resistance to High-Dose Melphalan Treatment in Multiple Myeloma

Paul J. Hengeveld, B.Sc., Geoffrey M. Matthews, PhD, Yiguo Hu, MDPhD, Michal Sheffer, PhD, Megan A. Bariteau, BSc, Haley I. Poarch, Eugen Dhimolea, PhD, Constantine S Mitsiades, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2484.
https://doi.org/10.1182/blood.V126.23.2484.2484
Published: 2015